目的：观察在经皮冠状动脉介入治疗（PCI）患者中硫酸氯吡格雷抵抗的发生情况。
Objective: To determine the relationship between risk factors of CHD and clopidogrel resistance, and CD62p expression after PCI.
目的观察两种硫酸氢氯吡格雷在经皮冠状动脉介入治疗中的临床应用效果。
Objective To investigate the clinical effect of two kinds of clopidogrel on percutaneous coronary intervention.
本发明还提供了所述的硫酸氢氯吡格雷片剂的制备方法。
The invention also provides a preparation method of the clopidogrel bisulfate tablet.
本发明涉及硫酸氢氯吡格雷固体制剂的制备工艺。
The invention relates to a preparation process of clopidogrel bisulfate solid preparation.
实验表明，本发明的硫酸氢氯吡格雷片剂的稳定性优异。
Experiment results show that the stability of the clopidogrel bisulfate tablet of the invention is excellent.
本发明涉及一种硫酸氢氯吡格雷的固体制剂、其颗粒及其制备方法。
The invention relates to a bisulfate clopidogrel solid preparation, particles and a preparation method thereof.
本发明涉及一种硫酸氢氯吡格雷的固体制剂、其颗粒及其制备方法。
The invention relates to a bisulfate clopidogrel solid preparation, particles and a preparation method thereof.
应用推荐